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Summary  Optical  coherence  tomography  is  a  new  endocoronary  imaging  modality  employing
near infrared  light,  with  very  high  axial  resolution.  We  will  review  the  physical  principles,
including  the  old  time  domain  and  newer  Fourier  domain  generations,  clinical  applications,
controversies  and  perspectives  of  optical  coherence  tomography.
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé  La  tomographie  par  cohérence  optique  est  une  modalité  d’imagerie  récente  endo-
coronaire utilisant  la  lumière  infrarouge,  caractérisée  par  une  haute  résolution.  Dans  cetpercutanée  ;
Athérosclérose  ;
Tomographie  par
cohérence  optique  ;
Syndrome  coronaire
aigu
article, on  discute  les  principes  physiques  en  discutant  l’ancienne  et  la  nouvelle  génération
de tomographie  par  cohérence  optique,  time  domain  et  Fourier  domain  respectivement.
© 2012  Elsevier  Masson  SAS.  Tou
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Table  1  Physical  properties  of  optical  coherence
tomography  and  intravascular  ultrasound.
IVUS  OCT
Wavelength  (m)  35—80  1.3
Energy  source  Ultrasound  Infrared
Penetration  (mm)  10  1—2.5
Axial  resolution  (m)  100—200  15—20
Lateral  resolution  (m)  200—300  20—40
IVUS: intravascular ultrasound; OCT: optical coherence
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ntroduction
ptical  coherence  tomography  (OCT)  is  a  new  imaging
odality,  used  for  the  ﬁrst  time  by  Huang  et  al.  in  1991
n  vitro  on  the  human  peripapillary  region  of  the  retina  and
oronary  arteries  [1].  OCT  is  based  on  near  infrared  light;
n  optical  beam  is  directed  at  the  tissues,  most  of  the  light
catters  and  only  the  small  portion  of  this  light  that  reﬂects
rom  subsurface  features  is  collected  and  forms  the  image
y  yielding  spatial  information  about  tissue  microstruc-
ure.  The  critical  advantage  of  OCT  over  ultrasonography
nd  magnetic  resonance  imaging  is  due  to  its  microme-
er  resolution  (about  10—15  m  of  tissue  axial  resolution)
2].
hysical principles and acquisition systems
CT  uses  low  coherent  near  infrared  light.  The  wavelength
sed  is  around  1300  nm  to  minimize  energy  absorption  in
he  light  beam  caused  by  protein,  water,  haemoglobin  and
ipids  [3].  The  physics  principle  that  allows  the  ﬁltering  of
cattered  light  is  optical  coherence  [4].  A  light  source  emits
 low-coherence,  laser  light  wave.  The  light  wave  reaches
 beam  splitter  or  a  partial  mirror,  which  splits  the  light
ave  in  half.  One  part  of  the  light  wave  travels  to  a  refe-
ence  mirror,  where  it  reﬂects  directly  back  towards  the
eam  splitter.  The  second  part  travels  to  the  sample  tis-
ue.  Depending  on  the  optical  properties  of  the  tissue,  some
mount  of  light  may  be  absorbed,  refracted  or  reﬂected
5—8]. Reﬂection  occurs  when  there  is  a  region  of  sharp
efractive  index  mismatch;  therefore  the  velocity  of  light
s  not  considered  constant  when  it  passes  through  different
edia.  Light  travels  faster  in  a  medium  of  low  refractive
ndex  compared  to  a  medium  of  high  refractive  index.  The
mount  of  reﬂection  depends  on  the  level  of  mismatch,
he  angle  and  the  polarization  of  the  incident  angle.  The
eﬂected  portion  of  the  light  travels  back  towards  the  beam
plitter,  where  it  meets  with  the  reference  light  wave.  The
nteraction  between  these  two  light  waves  is  the  basis  on
hich  OCT  produces  images  [7].  When  two  light  waves  of
he  same  wavelength  and  constant  phase  difference  meet,
hey  are  combined  through  superposition;  this  phenomenon
s  called  interference.  If  the  light  waves  are  in  phase,  they
dd  together  in  constructive  interference;  if  they  are  out
f  phase,  they  cancel  each  other  out  in  destructive  inter-
erence  [7].  When  the  sample  and  reference  light  waves
eet,  they  either  intensify  or  diminish  depending  on  how
he  sample  light  interacts  with  the  tissue  [8].  A  detector
ses  the  light  or  dark  pattern  produced  to  create  a  pixel
or  that  speciﬁc  region  [6].  OCT  cross-sectional  imaging  is
chieved  by  performing  successive  axial  measurements  of
ack-reﬂected  light  at  different  transverse  positions.  After
canning  a  whole  area,  a  full  image  of  the  tissue  may  be
roduced.
The  major  limitation  of  intracoronary  OCT  is  blood  atten-
ation  due  to  the  backscattering  properties  of  red  blood
ells,  thus  we  need  to  displace  blood  from  the  ﬁeld  of  view.
There  are  two  OCT  systems:  the  ﬁrst-generation  sys-
em  or  time  domain  OCT  and  the  new-generation  system
r  Fourier  domain  OCT.
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atomography.
ime domain OCT
ime  domain  OCT  (TD-OCT)  uses  an  occlusive  technique  that
equires  stopping  of  the  coronary  blood  ﬂow  by  soft  bal-
oon  inﬂation  [3,9,10].  The  pullback  speed  of  TD-OCT  ranges
etween  1  and  5  mm/s  [11—15]. TD-OCT  uses  a  broadband
ight  source  containing  a  moving  mirror  that  allows  scan-
ing  of  each  depth  position  in  the  image,  pixel  by  pixel.
his  mechanical  scanning  process  limits  the  rate  at  which
mages  can  be  acquired  [3].
TD-OCT  is  limited  by  the  risk  of  balloon  injury,  a  balloon-
essel  size  mismatch,  a  long  diseased  lesion  exceeding
0  mm,  the  inability  to  visualize  ostial  or  very  proximal
esions  and  the  inability  to  study  the  left  main  coronary
rtery.
ourier domain OCT
he  development  of  the  new-generation  or  Fourier
omain  OCT  (FD-OCT)  enables  high-speed  pullbacks
10—25  mm/second)  during  image  acquisition,  allowing  the
isualization  of  long  coronary  segments  in  a  much  reduced
cquisition  time  and  without  the  need  for  transient  occlu-
ion  of  the  coronary  artery.  The  non-occlusive  technique
equires  simultaneous  ﬂushing  with  a  viscous  iso-osmolar
olution  through  the  guiding  catheter  [2].  The  ﬂuid  infused
equires  a  viscosity  higher  than  that  of  blood;  non-occlusive
CT  image  acquisition  using  iodixanol  320  is  the  standard
ushing  solution  [2,11,12,15]. The  amount  of  iodixanol  320
sed  for  OCT  pull-back  is  usually  3-fold  greater  than  that
equired  for  standard  coronary  iodixanol  320.
FD-OCT  uses  a  wavelength-swept  laser  as  the  light  source
nd  the  reference  mirror  is  ﬁxed.  This  change  in  technology
esults  in  a  better  signal-to-noise  ratio  and  faster  sweeps,
llowing  a  dramatically  faster  image  acquisition  and  pull-
ack  speed  than  TD-OCT  [3,16,17].  Presently,  the  maximum
maging  speed  that  can  be  achieved  with  FD-OCT  is  limited
y  digital  data  transfer  and  storage  [18].
CT versus intravascular ultrasound
any  trials  have  compared  OCT  with  intravascular  ultra-
ound  (IVUS)  for  tissue  characterization  of  human  coronary
laques.  OCT  is  mainly  limited  by  its  penetration  depth.
ithin  its  penetration  depth  OCT  has  much  higher  sensitivity
nd  speciﬁcity  for  characterizing  calciﬁcation,  ﬁbrosis,  lipid
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nsitivity for plaque deﬁnition.
following  information  [21,25,26]: plaque  rupture,  identiﬁed
by  the  presence  of  ﬁbrous  cap  discontinuity  and  a  cavity
formation  within  the  plaque  (Fig.  4);  plaque  erosion,  cha-
racterized  by  loss  of  the  endothelial  lining  with  lacerations
of  the  superﬁcial  intimal  layers  and  without  ‘trans-cap’  rup-
tures;  intracoronary  thrombus  (a  red  thrombus  is  visualized
as  a  hypersignal  protruding  in  the  lumen,  with  a signal-
free  posterior  shadowing  due  to  attenuation  of  the  optical
beam  by  red  blood  cells;  a  white  thrombus  does  not  contain
red  blood  cells  and  can  be  thus  fully  visualized  with  OCT
[Fig.  5]).
Percutaneous coronary intervention and stent
implantation
Another  domain  of  interest  for  endocoronary  OCT  is  percuta-
neous  transluminal  angioplasty  and  stent  implantation.  OCT
was  able  to  assess  in-stent  restenosis,  in-stent  thrombosis
and  strut  coverage  in  bioresorbable  everolimus  stents  at  6Figure 1. Higher optical coherence tomography resolution and se
pool  intimal  hyperplasia  [19,20],  ﬁbrous  cap  erosion  and  rup-
ture,  intracoronary  thrombus  and  thin  cap  ﬁbroatheroma
[21]  (Fig.  1),  for  the  detection  of  stent  endothelialization,
strut  coverage  and  stent  apposition  and  expansion,  and
for  lumen  border  visualization  and  measurement  of  correct
lumen  area  [22]. As  for  IVUS,  the  critical  lumen  area  for
intermediate  lesions  is  4  mm2 [2].  Measurements  of  lumen
diameter  and  lumen  area  obtained  with  OCT  and  IVUS  were
highly  correlated,  although  OCT  measurements  were  found
to  be  7%  smaller  [2];  these  ﬁndings  may  be  more  relevant  in
small  vessels.  Compared  with  OCT,  IVUS  tends  to  underesti-
mate  stent  tissue  coverage  [23]. Table  1  shows  the  physical
properties  of  IVUS  and  OCT.
Clinical applications
Coronary plaque classiﬁcation
OCT  was  validated  in  vitro  for  atherosclerotic  plaque  char-
acterization  on  a  large  post-mortem  specimen  in  2002  [24]
and  later  in  vivo  human  studies  conﬁrmed  the  ability  of
OCT  to  characterize  the  plaque  [20]: ﬁbrous  plaques  are
characterized  by  a  homogeneous  rich  signal;  ﬁbrocalciﬁc
plaques  reveal  signal-poor  regions  with  sharply  delineated
borders;  lipid-rich  plaques  show  diffusely  bordered  signal-
poor  regions  (lipid  is  present  in  two  quadrants  in  any  of  the
images  within  a  plaque);  vulnerable  plaques  are  characte-
rized  by  a  thin-capped  ﬁbroatheroma,  deﬁned  as  a  ﬁbrous
cap  thickness  <  70  m  (Fig.  1),  within  a  lipid-rich  plaque;
microchannels  are  deﬁned  as  no-signal  tubuloluminal  struc-
tures  without  a  connection  to  the  vessel  lumen,  recognized
on  three  consecutive  cross-sectional  OCT  images  [2,14], and
are  seen  with  increased  neovascularization  of  atheroscle-
rotic  plaque  (Fig.  2).  Fig.  3  shows  a  typically  stable  and
calciﬁed  coronary  plaque  with  thick  ﬁbrous  cap.Acute coronary syndromes
In  the  setting  of  acute  coronary  syndromes,  OCT  is  feasi-
ble  and  can  yield,  in  addition  to  plaque  description,  the
Figure 2. Neo-channels (black arrow) could be visualized within
the plaque in some of our acute coronary syndrome patients.
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Figure 3. A typically stable coronary plaque, calciﬁed with a thick
ﬁbrous cap.
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aggressive  medical  therapy  as  well  as  percutaneous  angio-
plasty  and  stent  implantation.  Most  interesting  is  the  use  of
Fonths  and  1  and  3  years  [27—29]. The  vascular  response
stent  apposition  and  endothelialization)  after  drug-eluting
tent  and  bare-metal  stent  implantation  between  stable
nd  unstable  angina  pectoris  patients  was  also  success-
ully  assessed  by  OCT  [30—33]. OCT  analysed  the  impact  of
tent  strut  thickness  and  the  design  of  different  drug-eluting
tents  on  acute  stent  strut  apposition  [34]. Vessel  injury  (tis-
ue  prolapse,  luminal  protrusion  and  intrastent  dissection)
fter  stent  implantation  can  be  detected  by  OCT  [35,36].
ig.  6  shows  an  example  of  strut  malapposition  revealed  with
CT.
The  reproducibility  of  quantitative  OCT  for  stent  analysis
as  been  studied  and  showed  excellent  inter-  and  intraob-
erver  variability  for  strut  count,  strut  apposition  and  strut
issue  coverage  measurements  [37]. O
igure 5. (A) A red thrombus with a signal-free posterior shadowing; (igure 4. A plaque rupture site (arrow) with cavity formation
ithin the plaque.
ndications and clinical implications
efore or after stent implantation?
hen  OCT  is  performed  in  the  setting  of  percutaneous  angio-
lasty,  it  is  to  be  done  as  for  IVUS,  before  stent  implantation,
o  accurately  measure  the  vessel  dimensions  and  cross-
ectional  areas,  and  after  stent  implantation,  to  detect  good
tent  expansion  and  apposition  short  term  and  good  stent
ndothelialization  long  term.
or stable angina patients or during acute
oronary syndrome?
CT  is  helpful  in  some  stable  angina  patients  for  assessing
he  atherosclerotic  plaque  burden  and  detecting  markers
f  plaque  instability,  which  should  indicate  the  need  forCT  in  the  setting  of  acute  coronary  syndrome,  especially
B) A white thrombus fully visualized.
Optical  coherence  tomography  
s
f
b
a
h
m
p
D
T
c
R
[
[
[Figure 6. Localized malapposition of a drug-eluting stent.
to  detect  and  measure  the  thrombus  burden  and  analyse  the
underlying  plaque.
Implications
OCT  can  potentially  lead  to  a  change  in  strategies,  especially
in  the  setting  of  acute  myocardial  infarction.  Regarding  the
recently  developed  minimally  invasive  strategy  for  acute
myocardial  infarction,  consisting  of  a  conservative  strategy
after  thrombus  aspiration  in  Myocardial  Infarction  and  TIMI
grade  III  ﬂow  restoration,  OCT  can  document  and  support
this  strategy  by  showing  the  thrombus  component  of  the
residual  luminal  narrowing  and  by  studying  the  underlying
plaque.  This  can  avoid  or  delay  systematic  stent  implanta-
tion  in  a  prothrombotic  context.
Controversies
Haemorrhagic  components  appear  as  signal-poor  OCT
regions,  thus  distinguishing  haemorrhage  from  lipid  necrotic
pools  is  difﬁcult  [2].  Validation  studies  of  angiogenesis
identiﬁcation  are  still  lacking,  although  there  is  a  general
consensus  that  OCT  should  be  able  to  identify  microvessels
[2,14].  OCT  is  a  costly  technique  that  is  not  available  in
all  catheterization  centres  but  it  appears  to  be  cost  effec-
tive,  although  there  are  still  no  international  guidelines
regarding  OCT,  because  the  large  OCT  trials  studied  its  diag-
nostic  impact;  recently,  trials  studying  therapeutic  decisions
guided  by  OCT  have  been  published  and  others  are  still  ongo-
ing.  The  lack  of  international  guidelines  is  mainly  due  the
fact  that  this  is  a  recently  developedimaging  modality.
Perspectives
In  vivo  intracardiac  OCT  imaging  on  a  swine  model  through
percutaneous  access  was  able  to  acquire  high-quality  OCT
images  [38]. OCT  assessed  depolarization-related  artefacts
induced  by  the  birefringence  of  myocardium  and  readily
evaluated  catheter-tissue  contact.  This  is  a  critical  step
toward  image-guided  radiofrequency  ablation  in  a  clinical
[533
etting,  indicating  that  OCT  could  be  a  promising  technique
or  in  vivo  guidance  of  radiofrequency  ablation.
Transplant  allograft  vascular  disease  is  characterized
y  diffuse  concentric  ﬁbrointimal  proliferation.  Coronary
ngiography  underestimates  the  extent  of  the  disease.  OCT
as  the  potential  to  become  an  appropriate  imaging  tool  for
onitoring  the  effects  of  preventive  treatments  and  disease
rogression  [2].
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